Freedox Mortality Benefit In Stroke Could Be Clarified By Meta-Analysis
Executive Summary
The lower mortality trend for Pharmacia & Upjohn's Freedox in hemorrhagic stroke patients could be confirmed by a positive meta-analysis of clinical data from pivotal studies, FDA's Peripheral & Central Nervous System Drugs Advisory Committee suggested at its April 29 meeting.